ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

HIK Hikma Pharmaceuticals Plc

1,918.50
38.00 (2.02%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hikma Pharmaceuticals Plc LSE:HIK London Ordinary Share GB00B0LCW083 ORD SHS 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  38.00 2.02% 1,918.50 1,925.00 1,927.00 1,937.50 1,887.50 1,903.00 504,022 16:35:27
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 2.88B 190M 0.8594 22.41 4.26B
Hikma Pharmaceuticals Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker HIK. The last closing price for Hikma Pharmaceuticals was 1,880.50p. Over the last year, Hikma Pharmaceuticals shares have traded in a share price range of 1,614.50p to 2,222.00p.

Hikma Pharmaceuticals currently has 221,081,676 shares in issue. The market capitalisation of Hikma Pharmaceuticals is £4.26 billion. Hikma Pharmaceuticals has a price to earnings ratio (PE ratio) of 22.41.

Hikma Pharmaceuticals Share Discussion Threads

Showing 401 to 424 of 1875 messages
Chat Pages: Latest  27  26  25  24  23  22  21  20  19  18  17  16  Older
DateSubjectAuthorDiscuss
04/11/2016
09:10
Interim management statement due on 10th November.
tanners
04/11/2016
09:01
EDIT - oops I'm going mad!

I read somewhere trading update due and thought it said 5th November, but obviously not - I'll recheck!

tanners
04/11/2016
09:00
Does anybody know why the shares have tumbled this morning?
chrisgail
25/10/2016
06:11
Trying to understand the daily 50 p falls..Is it being played on the US election. Why this co..? Directors are millions down in total on their recent purchases. what does it he market know that they don't??
sandeep67
21/10/2016
11:26
Sold out rather make a profit then see it turn into a loss may buy in again
mrthomas
21/10/2016
08:42
Any thoughts that this might be to do with the likelihood that Clinton is going to be president and will prevent price gouging by pharma on products. Suspect that HIKMA price is badly influenced. Whereas HIK are producing generics mostly I gther.
gertie2shoes
21/10/2016
03:10
Thinking of selling as from 50% gain to less than 10% not sure why this is the case all in less than 6/8 months
mrthomas
20/10/2016
21:13
Us legislation?
r ball
04/10/2016
07:59
Hope springs eternal.
r ball
09/9/2016
09:11
Someone explain how repeated multi million pound share purchases over last weeks have contributed to daily declines in s/p. I nolonger understand this part
sandeep67
05/9/2016
09:35
well not really sure what to make of this share was up 50% a few weeks ago now about 20% think that its still in FT 100 so that helps
mrthomas
01/9/2016
17:42
No. Boehringer potential and Luke warm product lanches
r ball
01/9/2016
12:58
3 directors spent millions on shares each yesterday. Looks like Institutions want in by dropping the price to encourage scared selling. Can't see why the share price is inversing against the huge guys
sandeep67
01/9/2016
12:05
This share is getting too up and down for me now thinking of selling just hope stays up n FT 100 other wise will g down even more
mrthomas
24/8/2016
07:24
well there you go. Naff results by share price up.

Got to be on target for £30 now.

r ball
23/8/2016
20:19
Tomorrow is another day?
r ball
07/8/2016
12:41
Problem is the management discloses very little and this is the third time they've messed up in a year. First they said their gout treatment was fine and two months later they warned on it. Then they said actually 2015 revenues for Roxane were
much lower than expected and so they got a massive discount on the purchase price. Now they are saying 2016 revenues from this generics business will miss.

Clearly a pattern here.....but if you want to take the risk then good luck. I'd rather in invest in a company that gives more discoloured and whose management know how to forecast.

rrb
06/8/2016
10:49
should still be in the FT100 so the good and as you said good recovery not sure what the fuss was about still I think a long term hold
mrthomas
05/8/2016
10:21
great recovery
gucci
04/8/2016
08:46
Numis downgrade- target price about where it was yesterday.
greenpastures2
04/8/2016
08:20
Steady, or, boring, to put it another way maybe exactly what might be good to be invested in over the next year or two. They are growing the business at a very steady rate, it remains a long term hold in any portfolio.
chrisgail
04/8/2016
08:19
seems you were right can't see what the problem is but that a big mark down
mrthomas
04/8/2016
07:02
Won't be boring today. This will question Roxane acquisition value again.
rrb
30/7/2016
06:15
Still boring
r ball
Chat Pages: Latest  27  26  25  24  23  22  21  20  19  18  17  16  Older

Your Recent History

Delayed Upgrade Clock